Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
Product: Apo-Loratadine
Active Ingredient(s): Loratadine 10mg
Dosage Form: Tablet
New Zealand Sponsor: Apotex NZ Limited
Manufacturer(s): Apotex Inc, Weston, Ontario, Canada
Product: Videx EC
Active Ingredient(s): Didanosine 125mg
Dosage Form: Capsule
New Zealand Sponsor: Bristol-Myers Squibb (NZ) Limited
Manufacturer(s): Bristol-Myers Squibb Company, Evansville, Indiana, United States of America
Bristol-Myers Squibb Company, Mt Vernon, Indiana, United States of America
Product: Videx EC
Active Ingredient(s): Didanosine 200mg
Dosage Form: Capsule
New Zealand Sponsor: Bristol-Myers Squibb (NZ) Limited
Manufacturer(s): Bristol-Myers Squibb Company, Evansville, Indiana, United States of America
Bristol-Myers Squibb Company, Mt Vernon, Indiana, United States of America
Product: Videx EC
Active Ingredient(s): Didanosine 250mg
Dosage Form: Capsule
New Zealand Sponsor: Bristol-Myers Squibb (NZ) Limited
Manufacturer(s): Bristol-Myers Squibb Company, Evansville, Indiana, United States of America
Bristol-Myers Squibb Company, Mt Vernon, Indiana, United States of America
Product: Videx EC
Active Ingredient(s): Didanosine 400mg
Dosage Form: Capsule
New Zealand Sponsor: Bristol-Myers Squibb (NZ) Limited
Manufacturer(s): Bristol-Myers Squibb Company, Evansville, Indiana, United States of America
Bristol-Myers Squibb Company, Mt Vernon, Indiana, United States of America
Dated this 28th day of November 2001.
G. R. BOYD, Chief Advisor, Safety and Regulation (pursuant to delegation given by the Minister of Health on the 20th day of February 1997).